These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 27194321

  • 1. Antidepressants and the risk of hyponatremia: a Danish register-based population study.
    Leth-Møller KB, Hansen AH, Torstensson M, Andersen SE, Ødum L, Gislasson G, Torp-Pedersen C, Holm EA.
    BMJ Open; 2016 May 18; 6(5):e011200. PubMed ID: 27194321
    [Abstract] [Full Text] [Related]

  • 2. Hyponatremia associated with selective serotonin reuptake inhibitors, mirtazapine, and venlafaxine in Korean patients with major depressive disorder.
    Jung YE, Jun TY, Kim KS, Bahk WM.
    Int J Clin Pharmacol Ther; 2011 Jul 18; 49(7):437-43. PubMed ID: 21726494
    [Abstract] [Full Text] [Related]

  • 3. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, Cox GR, Merry SN, Meader N.
    Cochrane Database Syst Rev; 2021 May 24; 5(5):CD013674. PubMed ID: 34029378
    [Abstract] [Full Text] [Related]

  • 4. Recurrent hyponatremia associated with citalopram and mirtazapine.
    Bavbek N, Kargili A, Akcay A, Kaya A.
    Am J Kidney Dis; 2006 Oct 24; 48(4):e61-2. PubMed ID: 16997047
    [Abstract] [Full Text] [Related]

  • 5. Re: Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Al-Adwani A.
    Can J Psychiatry; 2005 Nov 24; 50(13):877; author reply 877-8. PubMed ID: 16483124
    [No Abstract] [Full Text] [Related]

  • 6. Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
    Bateman DN, Chick J, Good AM, Kelly CA, Masterton G.
    Eur J Clin Pharmacol; 2004 May 24; 60(3):221-4. PubMed ID: 15083251
    [Abstract] [Full Text] [Related]

  • 7. Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection.
    Jha MK, Minhajuddin A, Gadad BS, Greer TL, Mayes TL, Trivedi MH.
    Brain Behav Immun; 2017 Nov 24; 66():103-110. PubMed ID: 28698115
    [Abstract] [Full Text] [Related]

  • 8. Mirtazapine-associated hyponatremia presenting as delirium.
    Ghosh A, Hegde A, Grover S.
    Indian J Pharmacol; 2014 Nov 24; 46(4):448-9. PubMed ID: 25097290
    [Abstract] [Full Text] [Related]

  • 9. Antidepressants and the risk of hyponatremia: a class-by-class review of literature.
    De Picker L, Van Den Eede F, Dumont G, Moorkens G, Sabbe BG.
    Psychosomatics; 2014 Nov 24; 55(6):536-47. PubMed ID: 25262043
    [Abstract] [Full Text] [Related]

  • 10. Differences in Associations of Antidepressants and Hospitalization Due to Hyponatremia.
    Farmand S, Lindh JD, Calissendorff J, Skov J, Falhammar H, Nathanson D, Mannheimer B.
    Am J Med; 2018 Jan 24; 131(1):56-63. PubMed ID: 28803926
    [Abstract] [Full Text] [Related]

  • 11. Serotonin syndrome produced by a combination of venlafaxine and mirtazapine.
    Dimellis D.
    World J Biol Psychiatry; 2002 Jul 24; 3(3):167. PubMed ID: 12478883
    [No Abstract] [Full Text] [Related]

  • 12. Identifying Antidepressants Less Likely to Cause Hyponatremia: Triangulation of Retrospective Cohort, Disproportionality, and Pharmacodynamic Studies.
    Nagashima T, Hayakawa T, Akimoto H, Minagawa K, Takahashi Y, Asai S.
    Clin Pharmacol Ther; 2022 Jun 24; 111(6):1258-1267. PubMed ID: 35258103
    [Abstract] [Full Text] [Related]

  • 13. Mirtazapine versus other antidepressive agents for depression.
    Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, Churchill R, Furukawa TA.
    Cochrane Database Syst Rev; 2011 Dec 07; (12):CD006528. PubMed ID: 22161405
    [Abstract] [Full Text] [Related]

  • 14. Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
    Khouzam HR.
    Postgrad Med; 2016 Dec 07; 128(3):323-30. PubMed ID: 26821680
    [Abstract] [Full Text] [Related]

  • 15. An overview of the clinical efficacy of mirtazapine.
    Benkert O, Muller M, Szegedi A.
    Hum Psychopharmacol; 2002 Jun 07; 17 Suppl 1():S23-6. PubMed ID: 12404666
    [Abstract] [Full Text] [Related]

  • 16. Safety and tolerability of the new antidepressants.
    Nelson JC.
    J Clin Psychiatry; 1997 Jun 07; 58 Suppl 6():26-31. PubMed ID: 9227670
    [Abstract] [Full Text] [Related]

  • 17. Mirtazapine: clinical overview.
    Gorman JM.
    J Clin Psychiatry; 1999 Jun 07; 60 Suppl 17():9-13; discussion 46-8. PubMed ID: 10446735
    [Abstract] [Full Text] [Related]

  • 18. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L.
    J Affect Disord; 2016 May 15; 196():225-33. PubMed ID: 26938965
    [Abstract] [Full Text] [Related]

  • 19. [Mirtazapine versus other antidepressive agents for depression].
    Knud Larsen J.
    Ugeskr Laeger; 2012 Nov 12; 174(46):2864-6. PubMed ID: 23153468
    [Abstract] [Full Text] [Related]

  • 20. Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study.
    Kjaersgaard MI, Parner ET, Vestergaard M, Sørensen MJ, Olsen J, Christensen J, Bech BH, Pedersen LH.
    PLoS One; 2013 Nov 12; 8(8):e72095. PubMed ID: 24015208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.